Abstract
Summary
LPI (LP Information)' newest research report, the “Wearable Glucometers Industry Forecast” looks at past sales and reviews total world Wearable Glucometers sales in 2022, providing a comprehensive analysis by region and market sector of projected Wearable Glucometers sales for 2023 through 2029. With Wearable Glucometers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Wearable Glucometers industry.
This Insight Report provides a comprehensive analysis of the global Wearable Glucometers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Wearable Glucometers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Wearable Glucometers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Wearable Glucometers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Wearable Glucometers.
The global Wearable Glucometers market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Wearable Glucometers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Wearable Glucometers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Wearable Glucometers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Wearable Glucometers players cover Dexcom, Abbott Laboratories, Bayer, Johnson and Johnson, Medtronic, DiaMon Tech GmbH, F.Hoffman-La Roche, Terumo Corporation and Sanofi S.A, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Wearable Glucometers market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Smartwatches
Wristbands
Skin Patches
Smart Shoes And Socks
Contact Lenses
Segmentation by application
Hospitals
Specialty Clinics
Long-term Care Centers
Home Care Settings
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Dexcom
Abbott Laboratories
Bayer
Johnson and Johnson
Medtronic
DiaMon Tech GmbH
F.Hoffman-La Roche
Terumo Corporation
Sanofi S.A
Key Questions Addressed in this Report
What is the 10-year outlook for the global Wearable Glucometers market?
What factors are driving Wearable Glucometers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Wearable Glucometers market opportunities vary by end market size?
How does Wearable Glucometers break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Wearable Glucometers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Wearable Glucometers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Wearable Glucometers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Wearable Glucometers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Wearable Glucometers.
The global Wearable Glucometers market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Wearable Glucometers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Wearable Glucometers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Wearable Glucometers is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Wearable Glucometers players cover Dexcom, Abbott Laboratories, Bayer, Johnson and Johnson, Medtronic, DiaMon Tech GmbH, F.Hoffman-La Roche, Terumo Corporation and Sanofi S.A, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Wearable Glucometers market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Smartwatches
Wristbands
Skin Patches
Smart Shoes And Socks
Contact Lenses
Segmentation by application
Hospitals
Specialty Clinics
Long-term Care Centers
Home Care Settings
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Dexcom
Abbott Laboratories
Bayer
Johnson and Johnson
Medtronic
DiaMon Tech GmbH
F.Hoffman-La Roche
Terumo Corporation
Sanofi S.A
Key Questions Addressed in this Report
What is the 10-year outlook for the global Wearable Glucometers market?
What factors are driving Wearable Glucometers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Wearable Glucometers market opportunities vary by end market size?
How does Wearable Glucometers break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Wearable Glucometers Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Wearable Glucometers by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Wearable Glucometers by Country/Region, 2018, 2022 & 2029
2.2 Wearable Glucometers Segment by Type
2.2.1 Smartwatches
2.2.2 Wristbands
2.2.3 Skin Patches
2.2.4 Smart Shoes And Socks
2.2.5 Contact Lenses
2.3 Wearable Glucometers Sales by Type
2.3.1 Global Wearable Glucometers Sales Market Share by Type (2018-2023)
2.3.2 Global Wearable Glucometers Revenue and Market Share by Type (2018-2023)
2.3.3 Global Wearable Glucometers Sale Price by Type (2018-2023)
2.4 Wearable Glucometers Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Long-term Care Centers
2.4.4 Home Care Settings
2.4.5 Others
2.5 Wearable Glucometers Sales by Application
2.5.1 Global Wearable Glucometers Sale Market Share by Application (2018-2023)
2.5.2 Global Wearable Glucometers Revenue and Market Share by Application (2018-2023)
2.5.3 Global Wearable Glucometers Sale Price by Application (2018-2023)
3 Global Wearable Glucometers by Company
3.1 Global Wearable Glucometers Breakdown Data by Company
3.1.1 Global Wearable Glucometers Annual Sales by Company (2018-2023)
3.1.2 Global Wearable Glucometers Sales Market Share by Company (2018-2023)
3.2 Global Wearable Glucometers Annual Revenue by Company (2018-2023)
3.2.1 Global Wearable Glucometers Revenue by Company (2018-2023)
3.2.2 Global Wearable Glucometers Revenue Market Share by Company (2018-2023)
3.3 Global Wearable Glucometers Sale Price by Company
3.4 Key Manufacturers Wearable Glucometers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Wearable Glucometers Product Location Distribution
3.4.2 Players Wearable Glucometers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Wearable Glucometers by Geographic Region
4.1 World Historic Wearable Glucometers Market Size by Geographic Region (2018-2023)
4.1.1 Global Wearable Glucometers Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Wearable Glucometers Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Wearable Glucometers Market Size by Country/Region (2018-2023)
4.2.1 Global Wearable Glucometers Annual Sales by Country/Region (2018-2023)
4.2.2 Global Wearable Glucometers Annual Revenue by Country/Region (2018-2023)
4.3 Americas Wearable Glucometers Sales Growth
4.4 APAC Wearable Glucometers Sales Growth
4.5 Europe Wearable Glucometers Sales Growth
4.6 Middle East & Africa Wearable Glucometers Sales Growth
5 Americas
5.1 Americas Wearable Glucometers Sales by Country
5.1.1 Americas Wearable Glucometers Sales by Country (2018-2023)
5.1.2 Americas Wearable Glucometers Revenue by Country (2018-2023)
5.2 Americas Wearable Glucometers Sales by Type
5.3 Americas Wearable Glucometers Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Wearable Glucometers Sales by Region
6.1.1 APAC Wearable Glucometers Sales by Region (2018-2023)
6.1.2 APAC Wearable Glucometers Revenue by Region (2018-2023)
6.2 APAC Wearable Glucometers Sales by Type
6.3 APAC Wearable Glucometers Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Wearable Glucometers by Country
7.1.1 Europe Wearable Glucometers Sales by Country (2018-2023)
7.1.2 Europe Wearable Glucometers Revenue by Country (2018-2023)
7.2 Europe Wearable Glucometers Sales by Type
7.3 Europe Wearable Glucometers Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Wearable Glucometers by Country
8.1.1 Middle East & Africa Wearable Glucometers Sales by Country (2018-2023)
8.1.2 Middle East & Africa Wearable Glucometers Revenue by Country (2018-2023)
8.2 Middle East & Africa Wearable Glucometers Sales by Type
8.3 Middle East & Africa Wearable Glucometers Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Wearable Glucometers
10.3 Manufacturing Process Analysis of Wearable Glucometers
10.4 Industry Chain Structure of Wearable Glucometers
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Wearable Glucometers Distributors
11.3 Wearable Glucometers Customer
12 World Forecast Review for Wearable Glucometers by Geographic Region
12.1 Global Wearable Glucometers Market Size Forecast by Region
12.1.1 Global Wearable Glucometers Forecast by Region (2024-2029)
12.1.2 Global Wearable Glucometers Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Wearable Glucometers Forecast by Type
12.7 Global Wearable Glucometers Forecast by Application
13 Key Players Analysis
13.1 Dexcom
13.1.1 Dexcom Company Information
13.1.2 Dexcom Wearable Glucometers Product Portfolios and Specifications
13.1.3 Dexcom Wearable Glucometers Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dexcom Main Business Overview
13.1.5 Dexcom Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Wearable Glucometers Product Portfolios and Specifications
13.2.3 Abbott Laboratories Wearable Glucometers Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Wearable Glucometers Product Portfolios and Specifications
13.3.3 Bayer Wearable Glucometers Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Johnson and Johnson
13.4.1 Johnson and Johnson Company Information
13.4.2 Johnson and Johnson Wearable Glucometers Product Portfolios and Specifications
13.4.3 Johnson and Johnson Wearable Glucometers Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Johnson and Johnson Main Business Overview
13.4.5 Johnson and Johnson Latest Developments
13.5 Medtronic
13.5.1 Medtronic Company Information
13.5.2 Medtronic Wearable Glucometers Product Portfolios and Specifications
13.5.3 Medtronic Wearable Glucometers Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Medtronic Main Business Overview
13.5.5 Medtronic Latest Developments
13.6 DiaMon Tech GmbH
13.6.1 DiaMon Tech GmbH Company Information
13.6.2 DiaMon Tech GmbH Wearable Glucometers Product Portfolios and Specifications
13.6.3 DiaMon Tech GmbH Wearable Glucometers Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 DiaMon Tech GmbH Main Business Overview
13.6.5 DiaMon Tech GmbH Latest Developments
13.7 F.Hoffman-La Roche
13.7.1 F.Hoffman-La Roche Company Information
13.7.2 F.Hoffman-La Roche Wearable Glucometers Product Portfolios and Specifications
13.7.3 F.Hoffman-La Roche Wearable Glucometers Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 F.Hoffman-La Roche Main Business Overview
13.7.5 F.Hoffman-La Roche Latest Developments
13.8 Terumo Corporation
13.8.1 Terumo Corporation Company Information
13.8.2 Terumo Corporation Wearable Glucometers Product Portfolios and Specifications
13.8.3 Terumo Corporation Wearable Glucometers Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Terumo Corporation Main Business Overview
13.8.5 Terumo Corporation Latest Developments
13.9 Sanofi S.A
13.9.1 Sanofi S.A Company Information
13.9.2 Sanofi S.A Wearable Glucometers Product Portfolios and Specifications
13.9.3 Sanofi S.A Wearable Glucometers Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi S.A Main Business Overview
13.9.5 Sanofi S.A Latest Developments
14 Research Findings and Conclusion